We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Latest Industry Insights
Further Analysis of SARS-CoV-2 Genome Suggests It Is Stable
Industry Insight

Further Analysis of SARS-CoV-2 Genome Suggests It Is Stable

Two teams of scientists in Italy have collaborated on a project that further analyzed the SARS-CoV-2 genome from locally acquired samples. Technology Networks spoke with Professor Stefano Menzo, virologist, and Dr. Valerio Onofri, geneticist, affiliates of the Department of Excellence of Biomedical Science and Public Health, Marche Polytechnic University in Ancona, to learn more about the findings.
Developing Personalized Strategies To Maximize Cancer Therapy Success
Industry Insight

Developing Personalized Strategies To Maximize Cancer Therapy Success

Technology Networks recently spoke with Ofer Sharon, CEO of OncoHost, to learn more about ways to overcome patient resistance to immunotherapy and how proteomic profiling in oncology can aid diagnosis, prognosis and treatment of this incredibly complex disease.
Maintaining Optimal Blood Volume in COVID-19 Patients
Industry Insight

Maintaining Optimal Blood Volume in COVID-19 Patients

Technology Networks spoke to Michael Feldschuh, CEO, Daxor, to learn more about the importance of maintaining optimal blood volume, how the BVA-100 test can help to measure this, and how clinicians can use the information it provides to guide treatment of COVID-19 patients.
Scale and Speed in Proteomics Data Processing
Industry Insight

Scale and Speed in Proteomics Data Processing

Targeted proteomics start-up ProteiQ Biosciences recently announced the launch of InfineQ, its cloud-based solution software for near real-time processing of proteomics data. Technology Networks spoke with Arnoud Groen, CSO and co-founder of ProteiQ, to learn more about the solution and how it provides the scale and speed required for biomarker discovery.
Less Time Managing Inventory, More Time at the Bench? Yes Please
Industry Insight

Less Time Managing Inventory, More Time at the Bench? Yes Please

Lab efficiency is critical to speeding up development processes, yet many researchers find they spend more time managing consumables data than working at the bench. Lab informatics is one solution to this problem.
Sartorius Supports COVID-19 Vaccine Development Efforts
Industry Insight

Sartorius Supports COVID-19 Vaccine Development Efforts

Technology Networks spoke with Amelie Boulais, Vaccine Marketing Manager, Sartorius, to find out more about how Sartorius is supporting vaccine development at this critical time and the power of collaboration.
Advancing ALS Research With Omics Analysis Technology
Industry Insight

Advancing ALS Research With Omics Analysis Technology

Clinical trials produce a massive amount of medically relevant and highly sensitive data. Leveraging such data could make a difference to efforts to create more personalized, effective medicines. We talked to Medidata’s Sheila Diamond to find out more.
Blood Analysis in a COVID-19 Quarantine Lab
Industry Insight

Blood Analysis in a COVID-19 Quarantine Lab

Technology Networks spoke with Yossi Pollak, CEO, Sight Diagnostics, to learn more about OLO and how it is being used to minimize the challenges of handling and analyzing blood samples from COVID-19 infected patients.
Development of Immunotherapy To Treat COVID-19 in Progress
Industry Insight

Development of Immunotherapy To Treat COVID-19 in Progress

CEL-SCI Corporation recently announced that it is utilizing LEAPS peptide technology in efforts to develop an immunotherapy against the novel coronavirus caused by SARS-CoV-2. Technology Networks, spoke with Daniel Zimmerman, Ph.D. Senior VP of Research, Cellular Immunology at CEL-SCI Corporation, to learn more about the LEAPS technology.
Targeting the Vaginal Microbiome for Urogenital and Reproductive Health
Industry Insight

Targeting the Vaginal Microbiome for Urogenital and Reproductive Health

Technology Networks recently spoke with Dr Jacques Ravel (Chief Scientist of LUCA Biologics) and Luba Greenwood (CEO of LUCA Biologics) to learn more about what the vaginal microbiome is, how it can contribute to human pathology and the development of novel therapeutics in this space that are approaching clinical trials.
Advertisement